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Abstract
Background: Osteoarthritis (OA) is a leading cause of disability in developed nations. Total knee arthroplasty (TKA)
is a clinically effective treatment for people with end-stage knee OA, and represents one of the highest volume medical
interventions globally. However, up to one in three patients remain dissatisfied following TKA. Research indicates that
the strongest predictor of patient dissatisfaction following TKA is unmet expectations. This study will use a discrete
choice experiment (DCE) provided to patients to improve knowledge of the expected outcomes of TKA. This increased
knowledge is based on actual outcome data and is hypothesised to optimise patient expectations of TKA outcomes,
thereby increasing their satisfaction and self-reported health outcomes.
Methods/design: One hundred and thirty-two people with end-stage OA on the waiting list for TKA will be recruited
and randomly allocated to one of two groups using computer-generated block randomisation. A randomised controlled
trial (RCT) adhering to SPIRIT and CONSORT guidelines will evaluate the effect of administering a DCE prior to surgery on
patient-reported pain and function and satisfaction following TKA. Patients in the intervention arm will complete a
survey containing the DCE, compared to the control group who will complete a modified survey that does not contain
the DCE activity. The DCE contains information on actual risks of postoperative complications, as well as health status
after TKA. The DCE encourages patients to actively make trade-offs between risks and health outcomes to elicit their
preferences. Participants in both groups will be required to complete the survey after consenting to have the procedure,
but prior to surgery during their routine preadmission appointment at St. Vincent’s Hospital, Melbourne, Australia (SVHM).
Patients in both the intervention and control groups will also be required to complete a brief patient expectation survey
1 week prior to scheduled TKA. In addition, orthopaedic surgeons will complete a brief expectations survey for each
patient consented for TKA to compare matched surgeon and patient expectations for recovery following TKA. Primary
outcomes will be evaluated by a blinded examiner at 12 months post surgery using a validated self-reported pain and
physical function scale, and a validated patient satisfaction scale. Secondary outcomes will include a range of validated
measures of health and psychological wellbeing. All analyses will be conducted on an intention-to-treat basis using
linear regression models.
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Discussion: This study is the first of its kind to use a DCE to provide information to patients to optimise their
expectations of the outcomes of surgery. Reducing the rate of patient dissatisfaction commonly seen in patients
following TKA will help to reduce the burden associated with poor outcomes on the health system.
Trial registration: Australian New Zealand Clinical Trials Registry (ACTRN12615001226594p). Version 1; registered
on 9 November 2015.
Keywords: Total knee arthroplasty, Discrete choice experiment, Risk perception, Patient expectations, Outcomes
Abbreviations: CONSORT, Consolidated Standards of Reporting Trials; DCE, Discrete choice experiment;
OA, Osteoarthritis; OECD, The Organisation for Economic Co-operation and Development; RCT, Randomised
controlled trial; SMART, St. Vincent’s Melbourne Arthroplasty Outcomes Registry; SVHM, St. Vincent’s Hospital,
Melbourne; TKA, Total knee arthroplasty
Background
Osteoarthritis (OA) is one of the most disabling diseases
in developed countries and is responsible for significant
functional limitation in over 43 million people world-
wide, 27 million of whom are 60 years of age or older
[1]. Age is the strongest predictor of the development
and progression of OA, and as such the number of
people suffering with OA is expected to increase over
the coming years due to population ageing [2]. Total
knee arthroplasty (TKA) is a cost-effective treatment for
people with end-stage knee OA [3] that improves quality
of life by reducing pain, joint deformity and loss of func-
tion. It is a high-cost [4, 5] and high-volume procedure
[6], which dominates national surgical waiting lists. The
number of TKAs being performed each year has risen
markedly over the past decade and on average has dou-
bled in most Organization for Economic Co-operation
and Development (OECD) countries [2]. In Australia,
nearly 50,000 people underwent TKA in 2014 at an esti-
mated cost exceeding Australian $1 billion [5, 6].
Many studies have confirmed the beneficial impact of
TKA on pain, disability and quality of life on average [7, 8];
however, surgery is not without risk, and not without
heterogeneity in outcomes. In the short-term postoper-
ative period, there is a small risk of severe complica-
tions [9–11] and in the longer term there is the risk of
prosthesis failure, primarily through loosening, result-
ing in the need for complex revision surgery [6]. While
survival analysis is crucial for understanding the failure
rate of TKA, revision surgery alone as a sole index of
failure has been called into question because of the po-
tential for underestimating the problem [12]. In this
regard patients with joint pain and dysfunction may en-
dure years of dissatisfaction without undergoing revi-
sion surgery, with reports suggesting that 15–30 % of
patients are dissatisfied despite the procedures being
technically and radiologically satisfactory [13].
Not all patients undergoing TKA are at equal risk of
complications. A number of patient factors can increase
the risk of complications for individuals undergoing
TKA, including: age and gender [14], body mass index
[9, 10], ethnicity [15], psychological distress [16, 17],
baseline pain and functional disability [14], comorbidity
profile [9, 14] and radiographic OA severity [14]. For in-
dividuals considering TKA as a treatment option very
little is known about patients’ perspectives on acceptable
level of risk and how closely aligned or not this risk is
with their treating clinicians’.
Although patients and clinicians share similar goals of
maximising treatment benefits while minimising risk, they
may have different perspectives on trade-offs among bene-
fits and risks of treatment [18]. The acceptable level of risk
tolerated by a patient depends not only on the benefits
provided by the TKA (significant pain relief and improve-
ment in joint function) but also on the seriousness and
severity of the disease, the availability of other treatments
and other factors such as risk of complication [19]. To
date, patients’ assessments of risks and benefits of surgical
interventions have not been subjected to rigourous evalu-
ation. This is important because unrealistic patient expec-
tations and uninformed perceptions of potential benefits,
risks and limitations of surgery lead to dissatisfaction
following TKA [20].
It has been shown that more than one half of patients
undergoing TKA have expectations of surgery that ex-
ceed those of their surgeons; in contrast, only one quar-
ter expect less than their surgeons [21]. Patients with
higher levels of expectations than their surgeons antici-
pated greater improvements in activity levels and those
with lower expectations anticipated a higher incidence
of complications. It has also been reported that the rate
of dissatisfaction amongst TKA recipients with unmet
expectations is as high as 49 % compared to 6 % in those
whose expectations have been met [13].
This study will use a discrete choice experiment (DCE)
as an intervention to provide patients with more realistic
expectations of the outcomes of TKA, specified in terms
of operative and postoperative risks and improved func-
tion and quality of life. DCEs are choice models that de-
scribe, explain, and predict choices between two or more
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discrete alternatives, such as whether or not to undergo
surgery. The DCE is administered as part of a survey,
where patients are asked to compare a series of hypothet-
ical (but realistic) scenarios that describe risks and out-
comes of TKA, and asked to choose which they would
prefer [22]. By asking individuals to choose between
scenarios, the DCE elicits patients’ willingness to accept
trade-offs between features of specific treatments with dif-
ferent characteristics, thereby revealing their preferences
in terms of the relative importance of each characteristic
of the treatment [23, 24]. The impact of administering
a DCE prior to TKA on quality of life and satisfaction
post surgery will be examined in a randomised con-
trolled trial (RCT).
To date, patients’ assessments of risks and benefits of
surgical interventions, and specifically TKA, have not
been subjected to rigourous evaluation. The aim of this
research is to use DCEs to (1) explore how patients with
end-stage OA undergoing TKA balance risks and bene-
fits, (2) evaluate the effect of information from the DCE
on health outcomes and satisfaction following TKA, and
(3) compare matched surgeon and patient expectations
for recovery following TKA.
Methods
Experimental design
The design is a two-arm, blinded, randomised controlled
clinical trial comparing satisfaction and health outcomes
of TKA patients who are provided with a DCE prior to
undergoing TKA, with that of a control group. Patients
in the intervention arm will complete a survey contain-
ing the DCE. Patients in the control arm will complete a
survey that does not contain the DCE activity. Patients
will also complete a brief patient expectation survey
1 week prior to scheduled TKA. Outcomes will be com-
pared at 12 months after TKA. In addition, orthopaedic
surgeons will complete a brief expectations survey for
each patient consented for TKA. This will allow for a
matched surgeon/patient comparison of expectations for
recovery following TKA. The study strategy is registered,
constructed and presented according to the recommenda-
tions of the Standard Protocol Items: Recommendations
for Interventional Trials (SPIRIT) [25] (see Additional file 1
SPIRIT checklist) and Consolidated Standards of Reporting
Trials (CONSORT) guidelines [26].
Participants
Patients will include those with end-stage OA who are
on the waiting list at St. Vincent’s Hospital Melbourne,
Australia (SVHM) and scheduled to undergo TKA. After
patients have seen the orthopaedic surgeon and provided
consent for TKA, they attend the orthopaedic preadmis-
sion clinic for medical optimisation prior to surgery. Po-
tential patients will be identified and recruited for the
study during their attendance at this clinic, where they
undergo health assessment and education. The team
comprises an orthopaedic surgeon, registrar medical offi-
cer and nursing and allied health staff. Eligible patients
will include those who have had a previous TKA, in
order to determine whether knowledge and experience
gained through prior TKA will influence their response
to the DCE activity. Orthopaedic surgeons and registrars
will include those who perform TKAs at SVHM.
Inclusion criteria
These are (1) patients on the surgical waiting list for pri-
mary TKA for end-stage OA at SVHM, and (2) ortho-
paedic surgeons/registrars who consult at the orthopaedic
clinics at SVHM.
Exclusion criteria
These are (1) patients undergoing revision surgery or
surgery for neoplastic disease, and (2) inability to pro-
vide informed consent due to mental incompetence (e.g.
intellectual disability, dementia).
Intervention
Patients in the intervention arm will complete a survey
containing the DCE. The DCE includes items about post-
operative pain, stiffness, quality of life, complications and
adverse events (health states) following knee replacement
surgery. The remainder of the survey includes items about
how much improvement in symptoms patients expect fol-
lowing knee surgery, the level of control, attitude towards
taking risks, and the physical and emotional experiences
associated with knee pain. Participants will be required to
complete the survey prior to TKA during their routine
preadmission appointment at SVHM. The survey will take
approximately 30 min to complete. Patients will also be
required to complete a brief patient expectation survey
1 week prior to scheduled TKA, which will take approxi-
mately 5 min to complete. Participants will complete the
surveys electronically during their preadmission appoint-
ment. Surveys will be completed using a portable com-
puter with administrative assistance provided from the
study coordinator.
Discrete choice experiment development
Attributes and levels
To determine attributes and their levels, we used (1) pre-
vious literature, (2) data from an existing consecutive co-
hort of patients who underwent primary elective TKA
at SVHM between January 2006 and December 2012
(N = 2221, the St Vincent’s Melbourne Arthroplasty
Outcomes (SMART) Registry), (3) 40 face-to-face pa-
tient interviews, and (4) feedback from experts in the
field of orthopaedics and DCE development, including a
professor of orthopaedics and Head of the Department of
Dowsey et al. Trials  (2016) 17:416 Page 3 of 10
Surgery at SVMH; a professor of economics and Head of
the Health Economics Research Programme at the Uni-
versity of Melbourne; the Head of Arthritis Research for
the Department of Orthopaedics at SVHM; a rheumatolo-
gist at SVHM; and a general practitioner (GP). This re-
sulted in six attributes, with three levels defined for each
attribute (Table 1). Two attributes represented pain,
two attributes represented physical function, and two
attributes represented complications/risks associated
with TKA.
For complication/risk attributes, data were derived from
the SMART registry and used to identify the probabilities
of the most frequent surgical risks and complications that
occurred within 12 months of joint replacement surgery.
Specifically, attributes for adverse events were subdivided
into two categories: ‘Risk of having to go back into hos-
pital and have a second operation on your knee’ and ‘Risk
of getting a complication that requires seeing your GP or
specialist for further treatment’. The levels for these abso-
lute risk attributes were based on the minimum, median,
and maximum rate of identified risks over the period of
the SMART registry from 2006–2012.
For attributes related to measures of treatment efficacy
in terms of pain and function following TKA, these were
based on items derived from the Western Ontario and
McMaster Universities (WOMAC) Osteoarthritis Index
[27]. This is a widely used and validated questionnaire
specifically designed to evaluate the response to knee
OA treatment. Levels for these attributes were derived
from existing data in the SMART registry of patient
WOMAC scores at 12 months post surgery from all
elective primary TKAs performed during 2012 at SVHM
(N = 331).
DCE experimental design
The six attributes and corresponding levels described in
Table 1 give rise to a possible combination of 729 (36)
treatment outcome scenarios. As this full factorial design
of possible scenarios was not feasible to present to each
patient, a sample was generated using a fractional factor-
ial experimental design. An efficient design was gener-
ated using NGENE software, such that attributes were
varied independently from one another across the sce-
narios and that standard errors were minimised. This
model allows for multiple versions of the questionnaire,
reducing the burden on patients and increasing the stat-
istical efficiency of the study. Two versions of the DCE
questionnaire were generated, each containing six differ-
ent choice sets. Each DCE questionnaire had the same
number of scenarios with the same attributes, but differ-
ent attribute levels in each questionnaire. The sample of
scenarios were then organised into pairwise profiles la-
belled ‘Choice A’ and ‘Choice B’, and participants were
asked to choose between the pair of choices in each of
the six choice sets. Furthermore, an opt-out option was
included at the end of each choice set where patients
were asked if, given the scenarios presented, they would
still have the operation or prefer to remain in their
current health state. This opt-out option was included as
it reflects the voluntary nature of elective TKA in real
life. For an example of a discrete choice task see Table 2.
Pretesting
The DCE survey instrument was pretested to verify the
precise wording and framing of attributes and levels. The
salience of efficacy figures (i.e. icon arrays) and the word-
ing used to represent rates of adverse events was also
tested for ease of comprehension. We also ascertained
whether participants could manage the length of the ques-
tionnaire. Initial pretesting involved detailed face-to-face
interviews of 15 patients. Secondary testing involved the
administration of the pilot survey to 40 patients. Partici-
pants for pretesting were drawn from patients with end-
stage OA who were waitlisted for primary TKA at SVHM.
Patients were approached during their attendance at the
orthopaedic preoperative assessment clinic at SVHM after




1. Day-time pain 9–12 months
after surgery
No day-time pain, moderate
day-time pain, severe
day-time pain
2. Night-time pain 9–12 months
after surgery




3. Standing and walking on a flat
surface 9–12 months after surgery
No difficulty standing and
walking;
Moderate difficulty standing
and walking, severe difficulty
standing and walking
4. Bending to floor, rising from sitting,
going up and down stairs 9–12 months
after surgery
No difficulty bending to
floor, rising from sitting,
going up and down stairs
Moderate difficulty bending
to floor, rising from sitting,
going up and down stairs
Severe difficulty bending
to floor, rising from sitting,
going up and down stairs
Risk of complications:
5. Risk of having to go back into
hospital and have a second operation
on your knee
0 %, 7 %, 13 %
6. Risk of getting a complication
that requires seeing GP or specialist
for further treatment
0 %, 10 %, 21 %
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consent for TKA by an orthopaedic surgeon. The main
issue raised by patients was related to the timing of sce-
narios. The DCE task was based on possible scenarios
postoperatively where patients were asked to imagine that
they have had their knee replacement surgery. The de-
tailed interviews revealed that many patients tended to re-
late the attributes to their current health state. Therefore,
the wording of attributes was changed to reinforce the im-
portance of post-surgery in the final design of the survey.
Overall, patients felt that the DCE covered all important
aspects relating to the postoperative period following knee
replacement surgery.
Standard of care
Patients will undergo surgery and postoperative care as per
SVHM’s routine TKA programme which has been standar-
dised through the use of clinical pathway protocols and
validated in a RCT [28]. Postdischarge rehabilitation in-
volves either an in-patient or a home-based physiotherapy
programme which is predetermined during preadmission
clinic assessment using a validated discharge predictor tool
[29]. Both programmes are standardised and conducted
through SVHM’s in-patient or Hospital-In-The-Home
service and are followed by referral to a community-based
physiotherapy programme, based on the locality of the
Table 2 Example of a discrete choice task
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patient’s residence. At the preadmission clinic, all patients
receive an instruction booklet outlining the continuum of
care for TKA. All patients are reviewed post surgery in the




Demographic information collected at baseline will in-
clude age, gender, comorbidities, body mass index and
socioeconomic data.
Primary outcomes: will be (1) changes in patient-
reported knee pain and disability between baseline and
12 months post TKA, and (2) patient satisfaction.
Pain and physical function will be measured on the
WOMAC Osteoarthritis Index [27]. The WOMAC con-
sists of 24 items covering three subscales: pain (five items),
stiffness (two items) and physical function (17 items). The
pain and physical function subscales will be used, each sub-
scale transformed to a score ranging from 0 to 100, with a
higher score indicating greater pain and physical function.
The WOMAC is a widely used questionnaire specifically
designed to evaluate knee and hip OA [30, 31]. Patient
satisfaction will be derived from the Self-administered
Patient Satisfaction Scale (SAPS) for primary knee
arthroplasty, a validated self-administered patient satis-
faction scale [30]. Patients will be mailed both ques-
tionnaires at 12 months and patients who do not attend
review clinics will complete the post-TKA surveys via
phone call from a study coordinator, who will be blinded
to intervention allocation.
Secondary outcomes: will be (1) changes in patient-
reported psychological wellbeing between baseline and
12 months post TKA. Psychological wellbeing will be de-
rived from the 12-item short form version of the Vet-
erans RAND Health Survey mental component score
(VR-12) [31], (2) differences in expectations of recovery
between baseline and 1 week prior to scheduled TKA
for patients in the intervention arm. Recovery expecta-
tions following TKA will be measured using the 19-item
Hospital for Special Surgery: Knee Surgery Expectations
Survey [32]. This measure forms a part of the larger
study survey, but is measured before patients complete
the DCE component, (3) concordance between matched
surgeon and patient expectation for recovery following
TKA. Surgeons will complete the same expectation sur-
vey as patients immediately following consultation and
consent for surgery. The surgeon and patient expect-
ation survey will then be paired for analysis.
Additional measures
The following independent (predictor) variables will be
assessed prior to surgery at baseline during patient pre-
admission appointments:
 Personality: measured using the Big Five Personality
Inventory, a 15-item questionnaire [33]
 Control: measured using the Locus of Control,
a 7-item questionnaire [34]
 Risk Attitudes: single-item scale used in the British
Household Panel Survey [35]
 Optimism: measured using the 10-item Life
Orientation Test-revised Questionnaire [36]
 Fear avoidance beliefs: measured using the 5-item
Fear Avoidance Beliefs Questionnaire [37]
 Catastrophising: measured using the 13-item Pain
Catastrophising Scale [38]
 Charlson Comorbidity Score (CCS) [39]. This is a
weighted index for classifying comorbidities’ severity,
validated for estimating the risk of morbidity and
mortality in longitudinal studies
 Charnley classification [40]: stratifies patients by
the presence of arthritis in one or more large
joints; a condition that impairs walking; previous
total joint arthroplasty (TJA) on the contra-lateral
knee and/or hips
 Baseline radiographic disease severity as assessed by
the Kellgren-Lawrence grading [41]
Timelines
This is a 1-year study with an anticipated start date of
February 2016 and end date of January 2017. See Table 3
for SPIRIT schedule of study including enrolment, inter-
ventions and assessments.
Table 3 SPIRIT trial study schedule
Activity/assessment Enrolment Randomisation t1 t2 t3 t4
−t1 0




Baseline assessments batterya X
Expectation surveyb X
Total knee arthroplasty X
12-month assessmentsc X
aBaseline assessments will be given to patients during their preadmission
appointments and completed with the assistance of the study coordinator.
Assessment items include: Western Ontario and McMaster Universities
(WOMAC) Osteoarthritis Index; Veterans RAND Health Survey mental
component score (VR-12); Big Five Personality Inventory; Locus of Control; Risk
Attitudes; Hospital for Special Surgery: Knee Surgery Expectations Survey; Fear
Avoidance Beliefs Questionnaire; Pain Catastrophising Scale; Life Orientation
Test-revised Questionnaire; and the DCE survey for patients in the
intervention group
bPatients will complete the Hospital for Special Surgery: Knee Surgery
Expectations Survey 1 week prior to scheduled TKA via phone with
study coordinator
c12-month assessment will be given to patients at their 1-year post-TKA surgical
review visit. Assessments include: WOMAC; VR-12 (this assessment is routine for
all patients undergoing TKA)
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Sample size
Intervention effectiveness will be evaluated by comparing
change in the primary outcome measure between groups.
We aim to detect minimum clinically important improve-
ment (MCII) in the WOMAC. The sample size calculation
was based on the following parameters: (1) an alpha
value = 0.05, two-sided; (2) power = 80 %. To demon-
strate a minimum clinically important difference in
WOMAC scores of 15 points (SD [42]), between groups,
the sample size required for each group is 45.
To demonstrate a difference in satisfaction the sample
size calculation was based on the following parameters:
(1) an alpha value = 0.05, two-sided; (2) power = 80 %;
(3) expected rates of satisfaction at 1 year post TKA of
77 % for patients in the intervention arm prior to con-
senting to surgery compared to 51 % for patients under-
going standard procedural consent. The expected rates
of satisfaction are derived from a recent study which re-
ported 49 % of patients whose expectations were not
met reported dissatisfaction with their TKA compared
6 % of patients whose expectations were met [13]. In-
complete data were reported in 17 % of the patient co-
hort and, therefore, these patients were not included in
the analysis. We have, therefore, assumed a worst case
scenario that these 17 % would have reported dissatisfac-
tion despite having their expectations met. Based on
these rates the sample size required in each group is 60.
To allow for a 10 % dropout of patients, we will recruit
132 patients in total (66 per arm). This estimate is con-
servative based on our prior RCTs in TKA [43, 44],
where we have achieved >95 % retention at 12 months.
Recruitment
Patients will be approached about participation in the
study after consent for TKA, but before surgery. We chose
to administer the DCE activity post consent for surgery so
as to maintain surgeon blinding and avoid any influence
the DCE activity may have on the consent process itself. It
is possible but unlikely that completing the DCE activity
may influence the decision to undergo TKA. Since we are
using an intent-to-treat design, should this occur our stat-
istical analyses will account for missing data by using mul-
tiple imputations. Potential patients waitlisted for TKA
identified as meeting the inclusion criteria will receive
both verbal and written information about the require-
ments for participation including: (1) verbal explanation
of the project by the study coordinator upon initial con-
tact during their attendance at the orthopaedic preadmis-
sion clinic at SVHM, (2) a detailed outline of the project
content and required commitment in the Patient Informa-
tion and Consent Form (see Additional file 2: Participant
Information and Consent Form). Patients agreeing to take
part in the trial will be required to provide written in-
formed consent. Informed consent will be obtained by the
research associate only after the patient has read and fully
understands the details of the project.
Randomisation and masking
Following study consent, eligible patients will be randomly
assigned in a ratio of 1:1 to either complete the intervention
survey or the control survey prior to surgery. Block
randomisation will be performed by a computer-generated
random assignment sequence prepared in advance.
Opaque, numbered, tamperproof envelopes containing
assignment will be prepared. Considerable effort will be
made to avoid observer bias through separation of roles
and blinding of trial staff. A research assistant inde-
pendent of patient recruitment and data collection will
be responsible for patient management. The research
associate (who will be responsible for patient consent)
will be blinded to group allocation. The surgeons in-
volved in the consent of patients for TKA will have no
role in the assignment process. Consenting surgeons
will be blinded to patient allocation. In addition, out-
come ascertainment will be blinded. Upon completion
of the study, a biostatistician blinded to group alloca-
tion will analyse outcome data.
Data management
All data will be stored on a password-protected com-
puter kept in a secure locked facility and only accessible
to the chief investigators and the trial coordinator as
approved by the SVHM Human Research Ethics Com-
mittee (HREC). At the completion of the study, out-
come data will be pooled and deidentified for analysis
by a statistician. Due to the short duration and minimal
risks of the trial, there will not be a data monitoring
committee. However, the chief investigator will be re-
sponsible for overseeing the trial and ensuring data
quality and completeness, including participant enrol-
ment, consent eligibility and forms, allocation to study
groups, data recording and timeliness of data collec-
tion. Furthermore, there will be no planned interim
analyses and stopping guidelines.
Statistical analysis
Statistical analysis will be by intention-to-treat. Categor-
ical variables will be analysed using chi-squared tests (or
Fisher’s exact test for small samples) while continuous
variables will be analysed using t tests (parametric) and
Mann-Whitney (non-parametric) tests for symmetrically
and asymmetrically distributed data, respectively. The
significance of differences in dichotomous data will be
tested using generalised estimating equations or a linear
mixed model. If there are chance imbalances in baseline
patient characteristics hypothesised to influence the main
outcomes, then statistical techniques that allow adjust-
ment for confounding variables will be used as secondary
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analyses. DCE data will be analysed based on extensions
to logistic regression, including multinomial logit models,
mixed logit models and generalised multinomial logit
models [45]. If there is more than 5 % missing data, sensi-
tivity analysis allowing for different assumptions, such as
the best or worst possible scenario, will also be reported
for the main outcomes of the study. Cohen’s kappa coeffi-
cient will be used to assess concordance between surgeon
and patient expectations.
Discussion
The outcomes of patients following TKA are beneficial on
average; however, research demonstrates that patient dis-
satisfaction following TKA is between 15 and 30 % [13].
One of the strongest predictors of patient dissatisfaction
following TKA is unmet patient expectations [21], sug-
gesting a misalignment between patients and surgeons
during the procedural consent process. Therefore, it is
important to assess patients’ preferences of acceptable risk
in undergoing TKA to reduce pain or improve function,
which has largely been unexplored. This project aims to
use DCEs to explore patient risk-benefit preferences of
surgery, and will use a RCT to determine whether apply-
ing a DCE prior to surgery improves patient expectations,
health outcomes and satisfaction.
DCEs are one of the most commonly used techniques
for assessing patients’ preferences in the health care do-
main. The current research is the first to use a DCE as
an intervention to improve patients’ knowledge about
the outcomes of a health care intervention. DCEs are
not only a useful way to present information, but also
require patients to engage through the process of mak-
ing trade-offs. This may help to ensure that the informa-
tion presented is more readily absorbed by patients as
opposed to simply reading an information leaflet. In re-
cent years there has been an increasing emphasis on the
importance of patient involvement in medical decision-
making [46–48]. These interventions can improve out-
comes by aligning patient and surgeon expectations of
surgery, which promotes greater patient satisfaction and
increases patient compliance [49].
It is proposed that the DCE validated in the current
protocol will aid in better realigning patient expectations
with those of their surgeons, which will result in im-
proved knowledge and more realistic expectations for re-
covery. Better aligning patient and surgeon expectations
will, therefore, likely result in improved postoperative
health outcomes and satisfaction amongst patients. Re-
ducing the rate of patient dissatisfaction commonly seen
in patients following TKA will help to reduce the burden
associated with poor outcomes on the health system (i.e.
ongoing outpatient consultations, prolonged require-
ment for allied health services, etc.). Furthermore, ex-
ploring whether risk-benefit preferences are influenced
by patient characteristics will provide critical informa-
tion for educating surgeons to understand the anxieties
faced by patients and for communicating these to pa-
tients undergoing surgery.
Trial status
Recruitment commencing February 2016.
Additional files
Additional file 1: SPIRIT checklist. (DOC 121 kb)
Additional file 2: Participant Information and Consent Form. (DOCX 26 kb)
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